Corrie E Erasmus Selected Research

Sialorrhea

12/2023	Predicting non-response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities.
11/2023	Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review.
3/2023	Best practice recommendations for speech-language pathology in children with neuromuscular disorders: A Delphi-based consensus study.
1/2021	Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders.
5/2020	An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities.
1/2020	Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.
1/2020	Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
12/2019	Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
11/2019	Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
1/2017	Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corrie E Erasmus Research Topics

Disease

13	Sialorrhea 12/2023 - 06/2010
5	Muscular Diseases (Myopathy) 03/2024 - 01/2019
5	Cerebral Palsy (Spastic Diplegia) 12/2023 - 08/2011
2	Atrophy 11/2023 - 01/2020
2	Intellectual Disability (Idiocy) 11/2018 - 03/2012
2	Hearing Loss (Hearing Impairment) 11/2018 - 12/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2024
1	Osteoporosis 12/2023
1	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 03/2023
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2023
1	Dysarthria (Spastic Dysarthria) 03/2023
1	Deglutition Disorders (Dysphagia) 03/2023
1	Myotonic Dystrophy (Dystrophia Myotonica) 03/2023
1	Metabolic Bone Diseases (Osteopenia) 01/2023
1	Muscle Weakness 01/2023
1	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2023
1	Muscular Dystrophies (Muscular Dystrophy) 08/2021
1	merosin negative Muscular dystrophy congenital 08/2021
1	Brody myopathy 01/2020
1	Developmental Disabilities (Developmental Disability) 11/2019
1	Urinary Retention 12/2018
1	Epilepsy (Aura) 11/2018
1	Seizures (Absence Seizure) 01/2017
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Cognitive Dysfunction 01/2017
1	Gastroesophageal Reflux (GERD) 01/2016
1	Constipation 01/2016
1	Scoliosis 01/2016
1	Myotonia 10/2014
1	Hereditary Spastic Paraplegia 12/2012
1	Glioma (Gliomas) 03/2009
1	Brain Neoplasms (Brain Tumor) 11/2002

Drug/Important Bio-Agent (IBA)

9	incobotulinumtoxinA FDA Link 12/2023 - 06/2010
9	Type A Botulinum Toxins (Botox)FDA Link 12/2023 - 06/2010
5	Botulinum Toxins (Botulinum Toxin)IBA 11/2023 - 08/2011
3	CalciumIBA 12/2023 - 01/2020
2	Vitamin D FDA LinkGeneric 12/2023 - 01/2023
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2023 - 01/2019
2	Retinaldehyde (Retinal)IBA 11/2018 - 12/2017
1	Muscle Proteins (Muscle Protein)IBA 03/2024
1	ConnectinIBA 03/2024
1	Serine (L-Serine)FDA Link 03/2024
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	Protein Kinases (Protein Kinase)IBA 03/2024
1	Laminin (Merosin)IBA 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Topiramate (Topamax)FDA LinkGeneric 01/2017
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2017
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2017
1	Voltage-Gated Sodium ChannelsIBA 01/2017
1	Acetazolamide (Diamox)FDA LinkGeneric 10/2014
1	Mexiletine (Mexitil)FDA LinkGeneric 10/2014
1	Phospholipases AIBA 12/2012
1	Phospholipases (Phospholipase)IBA 12/2012
1	MucinsIBA 06/2010
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2002

Therapy/Procedure

10	Injections 12/2023 - 06/2010
5	Therapeutics 01/2023 - 08/2011
4	Ligation 01/2021 - 12/2019
3	Aftercare (After-Treatment) 01/2020 - 08/2011
1	Artificial Respiration (Mechanical Ventilation) 11/2023
1	Oral Hygiene (Dental Hygiene) 03/2023
1	Enteral Nutrition (Feeding, Tube) 12/2018
1	Length of Stay 01/2017
1	Emergency Treatment 01/2017
1	Ketogenic Diet 01/2017
1	Radiotherapy 03/2009